ResearcherMayo ClinicActive in the last 2 years

Debabrata Mukhopadhyay

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3159-8928; OpenAlex author ID A5042923310. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in … Last author DOI 10.1053/j.gastro.2024.09.009 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hari Krishnareddy Rachamala · 1 shared paper, 2025 · strength 0.30
- Paper Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Ef… DOI 10.1053/j.gastro.2024.09.009 ↗
Krishnendu Pal · 1 shared paper, 2025 · strength 0.30
- Paper Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Ef… DOI 10.1053/j.gastro.2024.09.009 ↗
Santanu Bhattacharya · 1 shared paper, 2025 · strength 0.30
- Paper Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Ef… DOI 10.1053/j.gastro.2024.09.009 ↗
Naga Malleswara Rao Nakka · 1 shared paper, 2025 · strength 0.30
- Paper Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Ef… DOI 10.1053/j.gastro.2024.09.009 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.